🇺🇸 FDA
Pipeline program

IOV-4001

IOV-GM1-201

Phase 2 mab active

Quick answer

IOV-4001 for Unresectable Melanoma is a Phase 2 program (mab) at Iovance Biotherapeutics B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Iovance Biotherapeutics B.V.
Indication
Unresectable Melanoma
Phase
Phase 2
Modality
mab
Status
active

Clinical trials